Rediop

Rediop

timolol + dorzolamide

Manufacturer:

Aristopharma

Distributor:

KTZ
Full Prescribing Info
Contents
Dorzolamide hydrochloride, timolol maleate.
Description
Each ml contains Dorzolamide Hydrochloride USP equivalent to Dorzolamide 20 mg & Timolol Maleate BP equivalent to Timolol 5 mg.
Excipients/Inactive Ingredients: Preservative: Sodium Perborate BP 0.01%.
Vehicle: HPMC USP 0.5%.
Action
Pharmacology: Rediop contains Dorzolamide Hydrochloride and Timolol Maleate which reduce intraocular pressure (IOP) by combined action. Dorzolamide is human carbonic anhydrase II inhibitor which decreases aqueous humor secretion by slowing the formation of bicarbonate ions with subsequent reduction in sodium and fluid transport. Timolol is a non-selective beta adrenergic receptor blocker that does not have significant intrinsic sympathomimetic, direct myocardial depressant, or local anesthetic (membrane stabilizing) activity. It lowers IOP by decreasing the formation of aqueous humor in the ciliary epithelium.
Indications/Uses
Rediop Eye Drops is indicated for the treatment of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta blockers.
Dosage/Direction for Use
Instill one drop in the conjunctival sac of the affected eye(s) twice daily.
Contraindications
Contraindicated in patients who are hypersensitive to any of the components of this preparation.
Special Precautions
For ophthalmic use only.
Patients should remove their contact lenses prior to instilling this preparation and should not insert their lenses until 15 minutes after instillation of the preparation.
Use in children: Safety and effectiveness in children below the age of 2 years have not been established.
Use in the elderly: No overall differences in safety and effectiveness have been observed between elderly and other adult patients.
Use In Pregnancy & Lactation
Use in pregnancy: There are no adequate and well-controlled studies in pregnant women. Rediop should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Use in lactation: Caution should be exercised when Rediop is administered to a nursing mother.
Side Effects
Mild burning, ocular hyperemia, blurred vision may occur.
Storage
Store below 30°C & protect from light.
Discard 30 days after first opening.
ATC Classification
S01ED51 - timolol, combinations ; Belongs to the class of beta blocking agents. Used in the treatment of glaucoma.
Presentation/Packing
Eye drops 5 mL, 10 mL.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in